INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

COGNITION THERAPEUTICS INC

Filed

May 3, 2023

Period of Report

May 1, 2023

Accession Number

0001062993-23-010088